A pilot phase of voluntary newborn screening for SMA and SCID was launched in the Czech Republic beginning of January 2022.
All information about the project, sample collection, evaluation or participation opportunities can be found on the project website - https://nsc.uzis.cz/sma-scid/.
Information for health service providers can be found in the Methodological Guideline of Ministry of Health.
Information on newborn screening at the European Union level can be found on the NBS Alliance website.
In case of questions or uncertainties you can contact our crisis line on + 420 606 094 735.
Newborn screening in the media:
Broadcasting by ČT (Czech Television) 10.1.2022 (time 9:20)
Interview with Václav Hradilek for vzacni.cz
Report on the launch of the screening on vzacni.cz
The project Awareness campaign for the pilot phase of newborn screening for SMA and SCID is funded by Novartis.
